AMPG vs SIFY vs HCTI vs INFY

For growth investors, Sify Technologies Limited (SIFY) is the stronger pick with 11.

9% revenue growth year-over-year, versus -64. 8% for Healthcare Triangle, Inc. (HCTI). Infosys Limited (INFY) offers the better valuation at 16. 9x trailing P/E (16. 8x forward), making it the more compelling value choice. Analysts rate Sify Technologies Limited (SIFY) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Sify Technologies Limited (SIFY) delivered a total return of -9.

2%, compared to -100. 0% for Healthcare Triangle, Inc. (HCTI). Over 10 years, the gap is even starker: SIFY returned +147. 9% versus HCTI's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Infosys Limited (INFY) is the lower-risk stock at 0.

86β versus Healthcare Triangle, Inc. 's 3. 25β — meaning HCTI is approximately 280% more volatile than INFY relative to the S&P 500. On balance sheet safety, Infosys Limited (INFY) carries a lower debt/equity ratio of 9% versus 196% for Sify Technologies Limited — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Sify Technologies Limited (SIFY) is pulling ahead at 11.

9% versus -64. 8% for Healthcare Triangle, Inc. (HCTI). On earnings-per-share growth, the picture is similar: Healthcare Triangle, Inc. grew EPS 45. 6% year-over-year, compared to -877. 8% for Sify Technologies Limited. Over a 3-year CAGR, AMPG leads at 21. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Infosys Limited (INFY) is the more profitable company, earning 16.

4% net margin versus -118. 2% for AmpliTech Group, Inc. — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: INFY leads at 21. 1% versus -88. 7% for AMPG. At the gross margin level — before operating expenses — SIFY leads at 37. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, INFY (4.

5% yield) pays a dividend. AMPG, SIFY, HCTI do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Infosys Limited (INFY) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

86), 4. 5% yield). Healthcare Triangle, Inc. (HCTI) carries a higher beta of 3. 25 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (INFY: +76. 2%, HCTI: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (AMPG (Technology) and SIFY (Communication Services) and HCTI (Healthcare) and INFY (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: AMPG is a small-cap quality compounder stock; SIFY is a small-cap quality compounder stock; HCTI is a small-cap quality compounder stock; INFY is a mid-cap deep-value stock. INFY pays a dividend while AMPG, SIFY, HCTI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.